[go: up one dir, main page]

EA201170180A1 - Фармацевтические композиции соматотропных гормонов - Google Patents

Фармацевтические композиции соматотропных гормонов

Info

Publication number
EA201170180A1
EA201170180A1 EA201170180A EA201170180A EA201170180A1 EA 201170180 A1 EA201170180 A1 EA 201170180A1 EA 201170180 A EA201170180 A EA 201170180A EA 201170180 A EA201170180 A EA 201170180A EA 201170180 A1 EA201170180 A1 EA 201170180A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
somatotropic
hormones
somatotropic hormones
composition
Prior art date
Application number
EA201170180A
Other languages
English (en)
Inventor
Эндрю Нейлор
Эндрю Лестер Льюис
Лисбет Иллум
Original Assignee
Критикал Фармасьютикалз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39722152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201170180(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Критикал Фармасьютикалз Лимитед filed Critical Критикал Фармасьютикалз Лимитед
Publication of EA201170180A1 publication Critical patent/EA201170180A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение обеспечивает композицию, включающую (i) соматотропный гормон; (ii) поддающийся биологическому разложению полимерный компонент и (iii) модификатор высвобождения. Также обеспечены способ получения и применение такой композиции.
EA201170180A 2008-07-11 2009-07-10 Фармацевтические композиции соматотропных гормонов EA201170180A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0812740.9A GB0812740D0 (en) 2008-07-11 2008-07-11 Composition
PCT/GB2009/001727 WO2010004299A2 (en) 2008-07-11 2009-07-10 Composition

Publications (1)

Publication Number Publication Date
EA201170180A1 true EA201170180A1 (ru) 2011-08-30

Family

ID=39722152

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201170180A EA201170180A1 (ru) 2008-07-11 2009-07-10 Фармацевтические композиции соматотропных гормонов

Country Status (18)

Country Link
US (1) US20110257097A1 (ru)
EP (1) EP2317979A2 (ru)
JP (1) JP2011527329A (ru)
KR (1) KR20110040892A (ru)
CN (1) CN102131498A (ru)
AU (1) AU2009269818A1 (ru)
BR (1) BRPI0915857A2 (ru)
CA (1) CA2730325A1 (ru)
CL (1) CL2011000063A1 (ru)
CO (1) CO6331422A2 (ru)
CR (1) CR20110078A (ru)
EA (1) EA201170180A1 (ru)
GB (2) GB0812740D0 (ru)
IL (1) IL210555A0 (ru)
MA (1) MA32545B1 (ru)
MX (1) MX2011000259A (ru)
WO (1) WO2010004299A2 (ru)
ZA (1) ZA201101053B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0812742D0 (en) 2008-07-11 2008-08-20 Critical Pharmaceuticals Ltd Process
EP2165919A1 (de) 2008-09-19 2010-03-24 Sika Technology AG Verstärkte Struktur eines Fahrzeugs
CN101972212A (zh) * 2010-10-29 2011-02-16 华侨大学 超临界流体技术制备核壳型复合微球的方法
JP6476286B2 (ja) * 2014-09-29 2019-02-27 エルジー・ハウシス・リミテッドＬｇ Ｈａｕｓｙｓ，Ｌｔｄ． 重合体粉末の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100210509B1 (ko) * 1996-01-10 1999-07-15 성재갑 지속성 동물 성장 호르몬 제형 및 이의 제조 방법
US6444223B1 (en) * 1999-05-28 2002-09-03 Alkermes Controlled Therapeutics, Inc. Method of producing submicron particles of a labile agent and use thereof
KR20010002589A (ko) * 1999-06-16 2001-01-15 김윤 생리활성물질 함유 생분해성 고분자 마이크로스피어의 제조방법
KR100622996B1 (ko) * 2005-03-03 2006-09-14 한국과학기술원 약물이 봉입된 비다공성 고분자 미립 담체 및 이의 제조방법
DK2079767T3 (da) * 2006-10-11 2014-10-27 Tolmar Therapeutics Inc Fremstilling af bionedbrydelige polyestere med lave burst-egenskaber ved ekstraktion med et superkritisk fluid

Also Published As

Publication number Publication date
GB201102015D0 (en) 2011-03-23
CO6331422A2 (es) 2011-10-20
KR20110040892A (ko) 2011-04-20
MX2011000259A (es) 2011-04-05
AU2009269818A1 (en) 2010-01-14
CA2730325A1 (en) 2010-01-14
CR20110078A (es) 2011-05-03
GB0812740D0 (en) 2008-08-20
IL210555A0 (en) 2011-03-31
ZA201101053B (en) 2012-07-25
US20110257097A1 (en) 2011-10-20
WO2010004299A2 (en) 2010-01-14
JP2011527329A (ja) 2011-10-27
EP2317979A2 (en) 2011-05-11
MA32545B1 (fr) 2011-08-01
BRPI0915857A2 (pt) 2015-11-03
CN102131498A (zh) 2011-07-20
WO2010004299A3 (en) 2010-11-11
CL2011000063A1 (es) 2011-09-23
GB2474001A (en) 2011-03-30

Similar Documents

Publication Publication Date Title
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
EA201171481A1 (ru) Способ получения высококонцентрированного препарата иммуноглобулина для подкожного применения
DE602007005024D1 (de) Verfahren zur herstellung von konzentrierten tensidzusammensetzungen
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
PH12013500364A1 (en) Synthetic bile acid composition, method, and preparation
EA200800415A1 (ru) Удаление пероксида из носителя для доставки лекарственного средства
IN2014MN00380A (ru)
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
WO2009035540A3 (en) Analogues of exendin-4 and exendin-3
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
EA201170168A1 (ru) Комплекс (минерал-аминокислота)-полисахарид
EA200801049A1 (ru) Усовершенствованный тестостероновый гель и способ его применения
SV2009003221A (es) Composiciones de fenilalquilamino carbamato ref. prd2743svpct
JOP20180077A1 (ar) تركيبات وطرق لحمض صفراوي تخليقي
EA201390612A1 (ru) Биоразлагаемая композиция для доставки лекарственного средства
ATE509931T1 (de) Azaadamantanester- und carbamatderivate sowie anwendungsverfahren dafür
MY155410A (en) Compositions and devices
EA201170180A1 (ru) Фармацевтические композиции соматотропных гормонов
TN2009000447A1 (en) An extented-release composition comprising a somatostatin derivative in microparticles
ATE552832T1 (de) Antidepressivum-propharmaka
WO2010023473A3 (en) Crystalline form of sunitinib and processes for its preparation
NO20063868L (no) Vedvarende frigivende farmasoytisk sammensetning av indapamid
DK1976538T3 (da) Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.
UA101435C2 (ru) Аналоги нейропептида y, которые содержат по меньшей мере одну замену на синтетическую аминокислоту